Ali health works with nearly 50 pharmaceutical companies to ensure the supply of chronic diseases drugs

[trends of pharmaceutical network industry] compared with the general population, the patients with chronic diseases have relatively weak resistance and self immunity, so it is necessary to attach great importance to health management and take medicine on time to control the disease within a stable and life-threatening range However, during the current epidemic period, it is difficult for patients with chronic diseases to go out for dispensing In order to reduce the risk of cross infection after patients arrive at the hospital, on February 2, the National Health Insurance Bureau issued a notice to clearly implement the "long prescription" reimbursement policy, and to relax the prescription dosage of patients with chronic diseases such as hypertension and diabetes to 3 months, so as to ensure the long-term drug demand of the insured patients Then more and more response to the policy, to ensure the long-term drug demand of patients, while reducing the number of visits However, there are also differences between different regions For example, Shanghai, Beijing, Hangzhou and Anhui have reported that prescriptions can be issued for three months at a time; Tianjin and Quanzhou have reported that long-term prescriptions can be issued for two months at a time Therefore, the policies enjoyed by patients with chronic diseases in different places may be different For some patients who are inconvenient to go to the hospital and need medicine, what should they do? On February 13, nearly 50 domestic and foreign drug manufacturers, including Sanofi, dongyangguang, GlaxoSmithKline, AstraZeneca, Shiyao group, Pfizer puqiang, Novartis, Bayer, mosadong, Squibb, and so on, jointly launched the "chronic disease Fuli plan" on tmall's "buy medicine and don't go out" platform to ensure the online supply of chronic disease drugs during the epidemic, and provide online chronic disease Management services It is reported that the drugs involved in this cooperation cover chronic diseases such as liver disease, diabetes, cardiovascular and cerebrovascular diseases, and at the same time cover more than 1000 kinds of drugs of more than ten common diseases such as respiratory, neurological, anti infection, orthopedic, gout, gynecology, digestion, rheumatic immunity, Andrology, etc How to operate? According to the introduction, consumers only need to open Tmall / Taobao APP or Alipay search the name of the necessary drugs, or in these two APP search "buy medicine do not go out" or "dispensing not to go out", you can find the service page However, it is not that you can buy drugs by entering the page at will In order to ensure the safety of drug use, patients with chronic diseases need to submit the drug demand according to their actual conditions, and then arrange logistics distribution after multiple processes such as Internet doctors' follow-up prescription, pharmacists' review of prescriptions, etc It is understood that Ali health provides online personalized services such as disease health education, medication follow-up and medication guidance, disease care and follow-up reminders for patients who join the "chronic disease welfare plan", and links pharmaceutical companies to ensure that patients are provided with adequate dispensing and prices do not rise during the epidemic period Meanwhile, Alibaba health cooperates with Shunfeng to ensure that drugs can be delivered to patients quickly Data shows that the number of chronic diseases in China is about 300 million at present, among which the chronic diseases such as diabetes have shown a trend of younger development, which seriously affects the quality of life and health of residents In recent years, with the acceleration of modern life rhythm, the incidence rate of chronic diseases in China has been increasing Chronic diseases mainly include cardiovascular disease, tumor, chronic respiratory diseases and diabetes Many experts in the industry believe that in today's implementation of "healthy China" and advocacy of national fitness, we still need to change the traditional concept of chronic disease prevention and control, from the past "disease treatment first" to "health prevention first"